vs
Legacy Education Inc.（LGCY）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Legacy Education Inc.的1.9倍（$35.5M vs $19.2M），Legacy Education Inc.净利率更高（10.6% vs -304.2%，领先314.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 40.7%），Legacy Education Inc.自由现金流更多（$512.7K vs $-47.3M）
Legacy Education Inc.是一家专业教育培训服务商，主打财商素养、房地产投资、创业、个人财富管理相关课程，主要服务北美、欧洲及部分亚太地区的个人学习者，提供线下研讨会和线上数字化课程，帮助用户掌握实用的金融与商业技能。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LGCY vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.9倍
$19.2M
营收增速更快
RXRX
高出641.0%
40.7%
净利率更高
LGCY
高出314.9%
-304.2%
自由现金流更多
LGCY
多$47.8M
$-47.3M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.2M | $35.5M |
| 净利润 | $2.0M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 13.3% | -304.8% |
| 净利率 | 10.6% | -304.2% |
| 营收同比 | 40.7% | 681.7% |
| 净利润同比 | 46.0% | 39.6% |
| 每股收益（稀释后） | $0.15 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LGCYRXRX
| Q4 25 | $19.2M | $35.5M | ||
| Q3 25 | $19.4M | $5.2M | ||
| Q2 25 | $18.0M | $19.2M | ||
| Q1 25 | $18.6M | $14.7M | ||
| Q4 24 | $13.6M | $4.5M | ||
| Q3 24 | $14.0M | $26.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $13.8M |
净利润LGCYRXRX
| Q4 25 | $2.0M | $-108.1M | ||
| Q3 25 | $2.2M | $-162.3M | ||
| Q2 25 | $1.2M | $-171.9M | ||
| Q1 25 | $2.8M | $-202.5M | ||
| Q4 24 | $1.4M | $-178.9M | ||
| Q3 24 | $2.1M | $-95.8M | ||
| Q2 24 | — | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率LGCYRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率LGCYRXRX
| Q4 25 | 13.3% | -304.8% | ||
| Q3 25 | 13.9% | -3327.6% | ||
| Q2 25 | 11.1% | -916.8% | ||
| Q1 25 | 19.7% | -1297.9% | ||
| Q4 24 | 12.2% | -4042.4% | ||
| Q3 24 | 19.1% | -377.1% | ||
| Q2 24 | — | -697.4% | ||
| Q1 24 | — | -698.4% |
净利率LGCYRXRX
| Q4 25 | 10.6% | -304.2% | ||
| Q3 25 | 11.3% | -3135.3% | ||
| Q2 25 | 6.8% | -894.2% | ||
| Q1 25 | 15.2% | -1373.3% | ||
| Q4 24 | 10.3% | -3935.5% | ||
| Q3 24 | 14.9% | -367.5% | ||
| Q2 24 | — | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益（稀释后）LGCYRXRX
| Q4 25 | $0.15 | $-0.17 | ||
| Q3 25 | $0.16 | $-0.36 | ||
| Q2 25 | $0.07 | $-0.41 | ||
| Q1 25 | $0.21 | $-0.50 | ||
| Q4 24 | $0.10 | $-0.56 | ||
| Q3 24 | $0.21 | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.1M | $743.3M |
| 总债务越低越好 | $660.3K | $9.6M |
| 股东权益账面价值 | $46.1M | $1.1B |
| 总资产 | $73.1M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LGCYRXRX
| Q4 25 | $21.1M | $743.3M | ||
| Q3 25 | $20.6M | $659.8M | ||
| Q2 25 | $20.3M | $525.1M | ||
| Q1 25 | $17.3M | $500.5M | ||
| Q4 24 | $16.9M | $594.4M | ||
| Q3 24 | $21.5M | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务LGCYRXRX
| Q4 25 | $660.3K | $9.6M | ||
| Q3 25 | $776.9K | $11.9M | ||
| Q2 25 | $1.4M | $14.2M | ||
| Q1 25 | $1.0M | $16.4M | ||
| Q4 24 | $1.1M | $19.0M | ||
| Q3 24 | $758.2K | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益LGCYRXRX
| Q4 25 | $46.1M | $1.1B | ||
| Q3 25 | $43.7M | $1.0B | ||
| Q2 25 | $41.0M | $919.1M | ||
| Q1 25 | $39.3M | $933.9M | ||
| Q4 24 | $36.4M | $1.0B | ||
| Q3 24 | $32.6M | $524.6M | ||
| Q2 24 | — | $584.4M | ||
| Q1 24 | — | $401.2M |
总资产LGCYRXRX
| Q4 25 | $73.1M | $1.5B | ||
| Q3 25 | $72.1M | $1.4B | ||
| Q2 25 | $69.2M | $1.3B | ||
| Q1 25 | $67.1M | $1.3B | ||
| Q4 24 | $62.1M | $1.4B | ||
| Q3 24 | $50.6M | $726.5M | ||
| Q2 24 | — | $775.9M | ||
| Q1 24 | — | $557.8M |
负债/权益比LGCYRXRX
| Q4 25 | 0.01× | 0.01× | ||
| Q3 25 | 0.02× | 0.01× | ||
| Q2 25 | 0.03× | 0.02× | ||
| Q1 25 | 0.03× | 0.02× | ||
| Q4 24 | 0.03× | 0.02× | ||
| Q3 24 | 0.02× | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $512.7K | $-47.3M |
| 自由现金流率自由现金流/营收 | 2.7% | -133.1% |
| 资本支出强度资本支出/营收 | 2.8% | 3.5% |
| 现金转化率经营现金流/净利润 | 0.52× | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LGCYRXRX
| Q4 25 | $1.1M | $-46.1M | ||
| Q3 25 | $1.1M | $-117.4M | ||
| Q2 25 | $3.0M | $-76.4M | ||
| Q1 25 | $918.7K | $-132.0M | ||
| Q4 24 | $659.0K | $-115.4M | ||
| Q3 24 | $3.2M | $-59.2M | ||
| Q2 24 | — | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流LGCYRXRX
| Q4 25 | $512.7K | $-47.3M | ||
| Q3 25 | $809.7K | $-117.6M | ||
| Q2 25 | $2.9M | $-79.6M | ||
| Q1 25 | $596.6K | $-133.8M | ||
| Q4 24 | $466.8K | $-116.7M | ||
| Q3 24 | $2.9M | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率LGCYRXRX
| Q4 25 | 2.7% | -133.1% | ||
| Q3 25 | 4.2% | -2272.5% | ||
| Q2 25 | 16.2% | -413.9% | ||
| Q1 25 | 3.2% | -907.4% | ||
| Q4 24 | 3.4% | -2567.7% | ||
| Q3 24 | 21.1% | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度LGCYRXRX
| Q4 25 | 2.8% | 3.5% | ||
| Q3 25 | 1.3% | 4.7% | ||
| Q2 25 | 0.5% | 16.4% | ||
| Q1 25 | 1.7% | 12.4% | ||
| Q4 24 | 1.4% | 28.6% | ||
| Q3 24 | 1.7% | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率LGCYRXRX
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 2.45× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
